PROSPECT IN TREATMENT OF JUVENILE RHEUMATOID ARTHRITIS WITH ADALIMUMAB
<em>This review is dedicated to treatment of rheumatoid diseases in adults and children with one of TNF blockers adalimumab. The data from single, open9labeled, and multicenter double blinded placebo controlled studies of effectiveness and safety of adalimumab is presented. Analysis of many pu...
Main Authors: | , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
"Paediatrician" Publishers LLC
2008-01-01
|
Series: | Voprosy Sovremennoj Pediatrii |
Online Access: | http://vsp.spr-journal.ru:80/jour/article/view/1481 |
id |
doaj-b367f8ee6e4f49f9ac6703949c0be84c |
---|---|
record_format |
Article |
spelling |
doaj-b367f8ee6e4f49f9ac6703949c0be84c2020-11-24T23:27:32Zeng"Paediatrician" Publishers LLC Voprosy Sovremennoj Pediatrii1682-55271682-55352008-01-017654591481PROSPECT IN TREATMENT OF JUVENILE RHEUMATOID ARTHRITIS WITH ADALIMUMABE.I. Alexeeva0T.М. Bzarova1S.I. Valieva2R.V. Denisova3Scientific Center of Children's Health, Russian Academy of Medical Sciences, MoscowScientific Center of Children's Health, Russian Academy of Medical Sciences, MoscowScientific Center of Children's Health, Russian Academy of Medical Sciences, MoscowScientific Center of Children's Health, Russian Academy of Medical Sciences, Moscow<em>This review is dedicated to treatment of rheumatoid diseases in adults and children with one of TNF blockers adalimumab. The data from single, open9labeled, and multicenter double blinded placebo controlled studies of effectiveness and safety of adalimumab is presented. Analysis of many published information showed high activity and safety of adalimumab for treatment of rheumatoid arthritis, ankylosing spondylitis, rheumatoid uveitis in adults and children.</em><br /><strong><em>Key words: children, rheumatoid arthritis, juvenile rheumatoid arthritis, uveitis, treatment, adalimumab.</em></strong>http://vsp.spr-journal.ru:80/jour/article/view/1481 |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
E.I. Alexeeva T.М. Bzarova S.I. Valieva R.V. Denisova |
spellingShingle |
E.I. Alexeeva T.М. Bzarova S.I. Valieva R.V. Denisova PROSPECT IN TREATMENT OF JUVENILE RHEUMATOID ARTHRITIS WITH ADALIMUMAB Voprosy Sovremennoj Pediatrii |
author_facet |
E.I. Alexeeva T.М. Bzarova S.I. Valieva R.V. Denisova |
author_sort |
E.I. Alexeeva |
title |
PROSPECT IN TREATMENT OF JUVENILE RHEUMATOID ARTHRITIS WITH ADALIMUMAB |
title_short |
PROSPECT IN TREATMENT OF JUVENILE RHEUMATOID ARTHRITIS WITH ADALIMUMAB |
title_full |
PROSPECT IN TREATMENT OF JUVENILE RHEUMATOID ARTHRITIS WITH ADALIMUMAB |
title_fullStr |
PROSPECT IN TREATMENT OF JUVENILE RHEUMATOID ARTHRITIS WITH ADALIMUMAB |
title_full_unstemmed |
PROSPECT IN TREATMENT OF JUVENILE RHEUMATOID ARTHRITIS WITH ADALIMUMAB |
title_sort |
prospect in treatment of juvenile rheumatoid arthritis with adalimumab |
publisher |
"Paediatrician" Publishers LLC |
series |
Voprosy Sovremennoj Pediatrii |
issn |
1682-5527 1682-5535 |
publishDate |
2008-01-01 |
description |
<em>This review is dedicated to treatment of rheumatoid diseases in adults and children with one of TNF blockers adalimumab. The data from single, open9labeled, and multicenter double blinded placebo controlled studies of effectiveness and safety of adalimumab is presented. Analysis of many published information showed high activity and safety of adalimumab for treatment of rheumatoid arthritis, ankylosing spondylitis, rheumatoid uveitis in adults and children.</em><br /><strong><em>Key words: children, rheumatoid arthritis, juvenile rheumatoid arthritis, uveitis, treatment, adalimumab.</em></strong> |
url |
http://vsp.spr-journal.ru:80/jour/article/view/1481 |
work_keys_str_mv |
AT eialexeeva prospectintreatmentofjuvenilerheumatoidarthritiswithadalimumab AT tmbzarova prospectintreatmentofjuvenilerheumatoidarthritiswithadalimumab AT sivalieva prospectintreatmentofjuvenilerheumatoidarthritiswithadalimumab AT rvdenisova prospectintreatmentofjuvenilerheumatoidarthritiswithadalimumab |
_version_ |
1725551473970905088 |